Joseph Michael Fitzgerald sold $5.2M of Boston Scientific (BSX)

Executed Aug 1 2025, disclosed Aug 4 2025, 3 days later.

Value, as filed

$5.2M

50,000 sh × $104.63

Executed

Aug 1 2025

the trade date, as filed

Disclosed

Aug 4 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Joseph Michael Fitzgerald EVP & Group Pres, Cardiology profile →

Joseph Michael Fitzgerald (EVP & Group Pres, Cardiology) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Boston Scientific Corporation (BSX). The largest single filing was $5.0M of BSX (50,000 sh across 3 lots, as filed), executed Nov 3 2025.

The name

BSX

Boston Scientific Corporation BSX · Healthcare · 83 filings in 24 months ticker →

Healthcare · Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties wor…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Joseph Michael Fitzgerald in BSX

BSXSALE Boston Scientific Corporation $5.0M
50,000 sh across 3 lots
Exec Nov 3 2025
Filed Nov 4 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation $4.9M
50,000 sh across 2 lots
Exec Oct 1 2025
Filed Oct 1 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation $5.3M
50,000 sh across 2 lots
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation $5.3M
50,000 sh × $106.97
Exec Jul 1 2025
Filed Jul 2 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation $5.8M
56,372 sh × $102.88
Exec Jun 4 2025
Filed Jun 4 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation $11.3M
132,527 sh × $85.00
Exec Oct 7 2024
Filed Oct 8 2024 · 5:30 PM ET